Highlight news

A booster dose is now available to anyone in Australia aged 18 years and over who has completed their primary course of vaccination at least six-months ago.  

ATAGI has advised that in special circumstances, the six-month interval may be shortened to five months when needed for logistical reasons.  

Vaccination providers may choose to administer a booster dose a few weeks earlier than the six -month interval for logistical reasons, for example:  

•   for patients with a greater risk of severe COVID-19 in outbreak settings;  

•   if an individual is travelling overseas and will be away when their booster dose is due; or 

•   in outreach vaccination programs where access is limited.  

Providers should use their clinical judgement to determine whether it is appropriate to administer the dose early It should be noted that there are very limited data on benefit for boosters given prior to 20 weeks after completion of the primary course, and the duration of protection following boosters is not yet known. More information is available in ATAGI's clinical guidance on COVID-19 vaccines

All news

A booster dose is now available to anyone in Australia aged 18 years and over who has completed their primary course of vaccination at least six-months ago.  

ATAGI has advised that in special circumstances, the six-month interval may be shortened to five months when needed for logistical reasons.  

Vaccination providers may choose to administer a booster dose a few weeks earlier than the six -month interval for logistical reasons, for example:  

•   for patients with a greater risk of severe COVID-19 in outbreak settings;  

•   if an individual is travelling overseas and will be away when their booster dose is due; or 

•   in outreach vaccination programs where access is limited.  

Providers should use their clinical judgement to determine whether it is appropriate to administer the dose early It should be noted that there are very limited data on benefit for boosters given prior to 20 weeks after completion of the primary course, and the duration of protection following boosters is not yet known. More information is available in ATAGI's clinical guidance on COVID-19 vaccines